文献速递泌尿生殖腹部MRPETCT

前列腺切除术后生化复发影像检查:路在何方

Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed?
PubMed 文献 · AJR Am J Roentgenol · 2020-03-04

本文讨论前列腺切除术后生化复发患者中影像检查方式的演变角色。多参数MRI(mpMRI)聚焦手术床、区域淋巴结和骨骼;18F-氟环洛韦、11C-胆碱和PSMA配体PET/CT有助于检出局部和远处转移。转移低危患者首选mpMRI定位前列腺床复发及盆腔淋巴结和骨复发,并辅助活检和挽救治疗;转移高危患者可同时行mpMRI和全身PET/CT。68Ga-PSMA PET/MRI有潜力实现局部复发和转移病变评估的一站式检查,相关临床试验正在进行中。

要点

  • 转移低危患者首选mpMRI定位前列腺床复发及盆腔淋巴结和骨复发。
  • 转移高危患者可同时行mpMRI和全身PET/CT以评估局部和远处病变。
  • mpMRI可辅助引导活检和额外挽救治疗。

核心结论

  • 目前有多种影像检查方式可用于评估前列腺切除术后生化复发的前列腺癌患者。
  • 转移低危患者首选mpMRI定位前列腺床复发及盆腔淋巴结和骨复发,并辅助活检和挽救治疗。
  • 转移高危患者可同时行mpMRI和全身PET/CT。
  • 68Ga-PSMA PET/MRI有潜力实现局部复发和转移病变评估的一站式检查,相关临床试验正在进行中。

研究设计与样本

  • 本文为综述,讨论前列腺切除术后生化复发患者影像检查方式的演变角色。

关键影像表现/征象

  • mpMRI聚焦手术床、区域淋巴结和骨骼。
  • 18F-氟环洛韦、11C-胆碱和PSMA配体PET/CT有助于检出局部和远处转移。

临床应用与阅片要点

  • 转移低危患者首选mpMRI定位前列腺床复发及盆腔淋巴结和骨复发。
  • mpMRI可辅助引导活检和额外挽救治疗。
  • 转移高危患者可同时行mpMRI和全身PET/CT。
  • 68Ga-PSMA PET/MRI有潜力实现局部复发和转移病变评估的一站式检查,相关临床试验正在进行中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. In this article, we discuss the evolving roles of imaging modalities in patients presenting with biochemical recurrence after prostatectomy. CONCLUSION. Multiple imaging modalities are currently available to evaluate patients with prostate cancer presenting with biochemical recurrence after prostatectomy. Multiparametric MRI (mpMRI) focuses on the postsurgical bed as well as regional lymph nodes and bones. PET/CT studies using 18F-fluciclovine, 11C-choline, and prostate-specific membrane antigen (PSMA) ligands are useful in detecting locoregional and distant metastasis. Multiparametric MRI is preferred for patients with low risk of metastasis for localizing recurrence in prostate bed as well as pelvic lymph node and bone recurrence. Moreover, mpMRI aids in guiding biopsy and additional salvage treatments. For patients with high risk of metastatic disease, both mpMRI and whole-body PET/CT may be performed. PET/MRI using 68Ga-PSMA has potential to enable a one-stop shop for local recurrence and metastatic disease evaluation, and clinical trials of PET/MRI are ongoing.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Bhargava P, Ravizzini G, Chapin BF, et al. Imaging Biochemical Recurrence After Prostatectomy: Where Are We Headed? AJR Am J Roentgenol. 2020. PMID: 32130049. doi:10.2214/AJR.19.21905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。